Successful resection of intrahepatic cholangiocarcinoma with idiopathic thrombocytopenic purpura using thrombopoietin receptor agonist: a case report. [PDF]
Hoshino K +13 more
europepmc +1 more source
Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia. [PDF]
Jurczak W +6 more
europepmc +1 more source
Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures. [PDF]
Katsube T +4 more
europepmc +1 more source
Avatrombopag, an oral thrombopoietin receptor agonist: results of two double-blind, dose-rising, placebo-controlled Phase 1 studies. [PDF]
Kuter DJ, Allen LF.
europepmc +1 more source
Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study. [PDF]
Lim HJ +7 more
europepmc +1 more source
Citation clarification regarding feline eltrombopag in the "ACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and cats". [PDF]
Kim J, Kwak D.
europepmc +1 more source
A Paradoxical Case of Bleeding and Clots: The Hidden Thrombotic Threat in Immune Thrombocytopenic Purpura. [PDF]
Sarker NK +4 more
europepmc +1 more source
Romiplostim during pregnancy in refractory primary immune thrombocytopenia: Literature review and case series. [PDF]
Weinstein Mezan D +4 more
europepmc +1 more source
Effectiveness and Safety of Two Thrombopoietin Receptor Agonists: A Retrospective Cohort Study of Adults With Primary Immune Thrombocytopenia. [PDF]
Lanza DG +3 more
europepmc +1 more source

